| A mutation in the LDL receptor–related protein 5 gene results in the autosomal dominant high–bone-mass trait RD Little, C Folz, SP Manning, PM Swain, SC Zhao, B Eustace, ... The American Journal of Human Genetics 70 (1), 11-19, 2002 | 1524 | 2002 |
| CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia H Frangoul, D Altshuler, MD Cappellini, YS Chen, J Domm, BK Eustace, ... New England Journal of Medicine 384 (3), 252-260, 2021 | 1446 | 2021 |
| Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness BK Eustace, T Sakurai, JK Stewart, D Yimlamai, C Unger, C Zehetmeier, ... Nature cell biology 6 (6), 507-514, 2004 | 752 | 2004 |
| CD155/PVR plays a key role in cell motility during tumor cell invasion and migration KE Sloan, BK Eustace, JK Stewart, C Zehetmeier, C Torella, M Simeone, ... BMC cancer 4, 1-14, 2004 | 271 | 2004 |
| Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages C Lagathu, B Eustace, M Prot, D Frantz, Y Gu, JP Bastard, M Maachi, ... Antiviral therapy 12 (4), 489-500, 2007 | 227 | 2007 |
| Extracellular roles for the molecular chaperone, hsp90 BK Eustace, DG Jay Cell cycle 3 (9), 1096-1098, 2004 | 223 | 2004 |
| Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970 AB Hall, D Newsome, Y Wang, DM Boucher, B Eustace, Y Gu, B Hare, ... Oncotarget 5 (14), 5674, 2014 | 203 | 2014 |
| A paper-based invasion assay: Assessing chemotaxis of cancer cells in gradients of oxygen B Mosadegh, MR Lockett, KT Minn, KA Simon, K Gilbert, S Hillier, ... Biomaterials 52, 262-271, 2015 | 166 | 2015 |
| Fluorophore‐assisted light inactivation: A high‐throughput tool for direct target validation of proteins S Beck, T Sakurai, BK Eustace, G Beste, R Schier, F Rudert, DG Jay Proteomics 2 (3), 247-255, 2002 | 146 | 2002 |
| Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds ME Brousseau, EJ Schaefer, J Dupuis, B Eustace, P Van Eerdewegh, ... Journal of lipid research 41 (3), 433-441, 2000 | 145 | 2000 |
| Metabolic response of lung cancer cells to radiation in a paper-based 3D cell culture system KA Simon, B Mosadegh, KT Minn, MR Lockett, MR Mohammady, ... Biomaterials 95, 47-59, 2016 | 71 | 2016 |
| Fibroblasts enhance migration of human lung cancer cells in a paper-based coculture system G Camci-Unal, D Newsome, BK Eustace, GMC Whitesides Advanced healthcare materials, 2015 | 59 | 2015 |
| Modulation of the poliovirus receptor function C Unger, G Beste, C Zehetmeier, B Lain, C Torella, D Jay, B Eustace, ... US Patent App. 10/546,703, 2007 | 40 | 2007 |
| Chromophore‐assisted laser inactivation D Hoffman‐Kim, TJ Diefenbach, BK Eustace, DG Jay Methods in cell biology 82, 335-354, 2007 | 40 | 2007 |
| Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives YL Bennani, W Gu, A Canales, FJ Dı́az, BK Eustace, RR Hoover, ... Journal of medicinal chemistry 55 (5), 1920-1925, 2012 | 36 | 2012 |
| Neuropilin-1 inhibitors C Unger, G Beste, C Zehetmeier, B Lain, C Torella, J Niewohner, D Jay, ... US Patent App. 10/539,402, 2006 | 22 | 2006 |
| CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and B-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin Appear Well-Tolerated, Effective and Durable. MI Lin, E Paik, B Mishra, D Burkhardt, A Kernytsky, M Pettiglio, YS Chen, ... Blood 130, 284, 2017 | 20 | 2017 |
| Inhibitors of extracellular Hsp90 DG Jay, BK Eustace, T Sakurai US Patent 7,959,915, 2011 | 19 | 2011 |
| Global high-throughput screens for cellular function RS Hauptschein, BK Eustace, DG Jay Experimental hematology 30 (5), 381-387, 2002 | 16 | 2002 |
| Adapting chromophore-assisted laser inactivation for high throughput functional proteomics BK Eustace, A Buchstaller, DG Jay Briefings in Functional Genomics 1 (3), 257-265, 2002 | 12 | 2002 |
